We introduce the Ophiuchus DIsc Survey Employing ALMA (ODISEA), a project aiming to study the entire population of Spitzer -selected protoplanetary discs in the Ophiuchus Molecular Cloud (∼300 objects) from both millimeter continuum and CO isotopologues data. Here we present 1.3 mm/230 GHz continuum images of 147 targets at 0.2 (28 au) resolution and a typical rms of 0.15 mJy. We detect a total of 133 discs, including the individual components of 11 binary systems and 1 triple system. Fifty-three of these discs are spatially resolved. We find clear substructures (inner cavities, rings, gaps, and/or spiral arms) in 8 of the sources and hints of such structures in another 4 discs. We construct the disc luminosity function for our targets and perform comparisons to other regions. A simple conversion between flux and dust mass (adopting standard assumptions) indicates that all discs detected at 1.3 mm are massive enough to form one or more rocky planets. In contrast, only ∼50 discs (∼1/3 of the sample) have enough mass in the form of dust to form the canonical 10 M ⊕ core needed to trigger runaway gas accretion and the formation of gas giant planets, although the total mass of solids already incorporated into bodies larger than cm scales is mostly unconstrained. The distribution in continuum disc sizes in our sample is heavily weighted towards compact discs: most detected discs have radii < 15 au, while only 23 discs (∼15% of the targets) have radii > 30 au.
We present ALMA 1.3 mm continuum observations at 0.2 (25 au) resolution of Elias 2-24, one of the largest and brightest protoplanetary disks in the Ophiuchus Molecular Cloud, and report the presence of three partially resolved concentric
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.